The anamnestic neutralizing antibody response is critical for protection of mice from challenge following vaccination with a plasmid encoding the Japanese encephalitis virus premembrane and envelope genes

Journal of Virology

Volumn 73, Issue 7, 1999, Pages 5527-5534

  Konishi, Eiji ^a   Yamaoka, Masaoki ^a,d   Khin Sane Win, ^a   Kurane, Ichiro ^b,e   Takada, Kazuo ^b   Mason, Peter W ^c  

^a KOBE UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^b KINKI UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^c PLUM ISLAND ANIMAL DISEASE CENTER   (United States)

^d Hyogo Prefectural Institute of Public Health and Consumer Sciences   (Japan)

^e NATIONAL INSTITUTE OF INFECTIOUS DISEASES   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

DNA VACCINE; IMMUNOGLOBULIN M; NEUTRALIZING ANTIBODY;

ANTIBODY RESPONSE; ARTICLE; CELL FUNCTION; CYTOTOXIC T LYMPHOCYTE; FEMALE; IMMUNE RESPONSE; JAPANESE ENCEPHALITIS VIRUS; LETHAL DOSE; MOUSE; NONHUMAN; PLASMID; PRIORITY JOURNAL; VACCINATION; VIRUS GENE; VIRUS INFECTION; VIRUS PATHOGENESIS;

EID: 0032990412     PISSN: 0022538X     EISSN: None     Source Type: Journal    
DOI: 10.1128/jvi.73.7.5527-5534.1999     Document Type: Article

References (33)

1. Cecilia, D., D. A. Gadkari, N. Kedarnath, and S. N. Ghosh. 1988. Epitope mapping of Japanese encephalitis virus envelope protein using monoclonal antibodies against an Indian strain. J. Gen. Virol. 69:2741-2747.
2. Green, S., I. Kurane, S. Pincus, E. Paoletti, and F. A. Ennis. 1997. Recognition of dengue virus NS1-NS2a proteins by human CD4+ cytotoxic T lymphocyte clones. Virology 234:383-386.
3. Henchal, E. A., L. S. Henchal, and J. J. Schlesinger. 1988 Synergistic interactions of anti-NS1 monoclonal antibodies protect passively immunized mice from lethal challenge with dengue 2 virus. J. Gen. Virol. 69:2101-2107.
4. Hoke, C. H., A. Nisalak, N. Sangawhipa, S. Jatanasen, T. Laorakapongse, B. L. Innis, S. Kotchasenee, J. B. Gingrich, J. Latendresse, K. Fukai, and D. S. Burke. 1988. Protection against Japanese encephalitis by inactivated vaccines. N. Engl. J. Med. 319:608-614.
5. Kimura-Kuroda, J., and K. Yasui. 1988. Protection of mice against Japanese encephalitis virus by passive administration with monoclonal antibodies. J. Immunol. 141:3606-3610.
6. Kochel, T., S. J. Wu, K. Raviprakash, P. Hobart, S. Hoffman, K. Porter, and C. Hayes. 1997. Inoculation of plasmids expressing the dengue-2 envelope gene elicit neutralizing antibodies in mice. Vaccine 15:547-552.
7. Konishi, E. 1997. Monoclonal antibodies multireactive with parasite antigens produced by hybridomas generated from naive mice. Parasitology 115:387-393.
8. Konishi, E., I. Kurane, P. W. Mason, B. L. Innis, and F. A. Ennis. 1995. Japanese encephalitis virus-specific proliferative responses of human peripheral blood T lymphocytes. Am. J. Trop. Med. Hyg. 53:278-283.
9. + cytotoxic T lymphocytes in mice. Virology 227:353-360.
10. Konishi, E., P. W. Mason, and R. E. Shope. 1996. Enzyme-linked immunosorbent assay using recombinant antigens for serodiagnosis of Japanese encephalitis. J. Med. Virol. 48:76-79.
11. Konishi, E., S. Pincus, B. A. L. Fonseca, R. E. Shope, E. Paoletti, and P. W. Mason. 1991. Comparison of protective immunity elicited by recombinant vaccinia viruses that synthesize E or NS1 of Japanese encephalitis virus. Virology 185:401-410.
12. Konishi, E., S. Pincus, E. Paoletti, W. W. Laegreid, R. E. Shope, and P. W. Mason. 1992. A highly attenuated host-range restricted vaccinia virus strain, NYVAC, encoding the prM, E and NS1 genes of Japanese encephalitis virus prevents JEV viremia in swine. Virology 190:454-458.
13. Konishi, E., S. Pincus, E. Paoletti, R. E. Shope, T. Barrage, and P. W. Mason. 1992. Mice immunized with a subviral particle containing the Japanese encephalitis virus prM/M and E proteins are protected from lethal JEV infection. Virology 188:714-720.
14. Konishi, E., S. Pincus, E. Paoletti, R. E. Shope, and P. W. Mason. 1994. Avipox virus-vectored Japanese encephalitis virus vaccines: use as vaccine candidates in combination with purified subunit immunogens. Vaccine 12: 633-638.
15. Konishi, E., M. Yamaoka, Khin-Sane-Win, I. Kurane, and P. W. Mason. 1998. Induction of protective immunity against Japanese encephalitis in mice by immunization with a plasmid encoding JE virus premembrane and envelope genes. J. Virol. 72:4925-4930.
16. Kozak, M. 1986. Point mutations define a sequence flanking the AUG initiator codon that modulates translation by eukaryotic ribosomes. Cell 44:283-292.
17. Kreil, T. R., E. Maier, S. Fraiss, and M. M. Eibl. 1998. Neutralizing antibodies protect against lethal flavivirus challenge but allow for the development of active humoral immunity to a nonstructural virus protein. J. Virol. 72:3076-3081.
18. + cytotoxic T lymphocyte clones cross-reactive for dengue virus types 2, 3, and 4. Virology 240:169-174.
19. Lin, Y. L., L. K. Chen, C. L. Liao, C. T. Yeh, S. H. Ma, J. L. Chen, Y. L. Huang, S. S. Chen, and H. Y. Chiang. 1998. DNA immunization with Japanese encephalitis virus nonstructural protein NS1 elicits protective immunity in mice. J. Virol. 72:191-200.
20. Manickan, E., K. L. Karem, and B. T. Rouse. 1997. DNA vaccines - a modern gimmick or a boon to vaccinology? Crit. Rev. Immunol. 17:139-154.
21. Mason, P. W. 1989. Maturation of Japanese encephalitis virus glycoproteins produced by infected mammalian and mosquito cells. Virology 169:354-364.
22. Mason, P. W., J. M. Dalrymple, M. K. Gentry, J. M. McCown, C. H. Hoke, Jr., D. S. Burke, M. J. Fournier, and T. L. Mason. 1989. Molecular characterization of a neutralizing domain of the Japanese encephalitis virus structural glycoprotein. J. Gen. Virol. 70:2037-2049.
23. Mason, P. W., S. Pincus, M. J. Fournier, T. L. Mason, R. E. Shope, and E. Paoletti. 1991. Japanese encephalitis virus-vaccinia recombinants produce particulate forms of the structural membrane proteins and induce high levels of protection against lethal JEV infection. Virology 180:294-305.
24. Mathur, A., K. L. Arora, and U. C. Chaturvedi. 1983. Host defense mechanisms against Japanese encephalitis virus infection in mice. J. Gen. Virol. 64:805-811.
25. McAda, P. C., P. W. Mason, C. S. Schmaljohn, J. M. Dalrymple, T. L. Mason, and M. J. Fournier. 1987. Partial nucleotide sequence of the Japanese encephalitis virus genome. Virology 158:348-360.
26. Miura, K., T. Onodera, A. Nishida, N. Goto, and Y. Fujisaki. 1990. A single gene controls resistance to Japanese encephalitis virus in mice. Arch. Virol. 112:261-270.
27. + T cells. J. Gen. Virol. 77:705-714.
28. Phillpotts, R. J., K. Venugopal, and T. Brooks. 1996. Immunisation with DNA polynucleotides protects mice against lethal challenge with St. Louis encephalitis virus. Arch. Virol. 141:743-749.
29. Oya, A. 1988. Japanese encephalitis vaccine. Acta Paediatr. Jpn. 30:175-184.
30. Oya, A., and T. Okuno. 1975. Japanese encephalitis, p. 124-162. In Researcher's Association of the National Institute of Health (ed.), Experimental virology, 2nd ed. Maruzen Press Ltd., Tokyo, Japan. (In Japanese.)
31. Porter, K. R., T. J. Kochel, S. J. Wu, K. Raviprakash, I. Phillips, and C. G. Hayes. 1998. Protective efficacy of a dengue 2 DNA vaccine in mice and the effect of CpG immuno-stimulatory motifs on antibody responses. Arch. Virol. 143:997-1003.
32. Schmaljohn, C., L. Vanderzanden, M. Bray, D. Custer, B. Meyer, D. Li, C. Rossi, D. Fuller, J. Fuller, J. Haynes, and J. Huggins. 1997. Naked DNA vaccines expressing the prM and E genes of Russian spring summer encephalitis virus and Central European encephalitis virus protect mice from homologous and heterologous challenge. J. Virol. 71:9563-9569.
33. Zhang, M. J., M. J. Wang, S. Z. Jiang, and W. Y. Ma. 1989. Passive protection of mice, goats, and monkeys against Japanese encephalitis with monoclonal antibodies. J. Med. Virol. 29:133-138.